The Mount Sinai Health facility has carried out New York Town’s first process the usage of the HYDROS™ Robot Device, a state of the art era designed to regard benign prostatic hyperplasia (BPH), or an enlarged prostate. The minimally invasive process gives new hope for sufferers experiencing the indications of BPH, together with common urination, incomplete bladder emptying, and midnight urgency.
Urologists on the sanatorium not too long ago carried out the well being device’s first 3 procedures, with all sufferers responding smartly to the remedy and being discharged the next day to come.
This era supplies a much-needed possibility for males coping with the burdens of BPH. What makes HYDROS™ stand out is the way it combines complex imaging, robot precision, and a heat-free method to tissue elimination, all whilst keeping an important purposes like continence and sexual well being.”
Steven A. Kaplan, MD, Director of the Males’s Wellness Program, Mount Sinai Well being Device, and Professor of Urology, Icahn College of Drugs at Mount Sinai
BPH impacts greater than 50 p.c of guys over 60 and 80 to 90 p.c of guys over 70 years of age, making it one of the crucial prevalent prerequisites impacting older adults. Whilst noncancerous, the situation can considerably have an effect on high quality of lifestyles, resulting in discomfort, frustration, and way of life changes for thousands and thousands of guys.
The HYDROS™ device builds on conventional surgical strategies for treating BPH, comparable to transurethral resection of the prostate (TURP) and laser remedies, through introducing a number of notable inventions. It options synthetic intelligence (AI)-powered remedy making plans via FirstAssist AI™, an advanced symbol popularity tool that identifies vital anatomical constructions the usage of ultrasound. This era aids in developing customized remedy plans adapted to every affected person’s prostate anatomy.
Moreover, the device combines complex ultrasound imaging with virtual cystoscopy, offering surgeons with an in depth, multidimensional view of the prostate. This progressed visualization helps higher precision all the way through procedures and complements surgical making plans.
HYDROS™ additionally employs a robotic-assisted heat-free waterjet for tissue resection, taking into consideration efficient elimination of obstructive tissue whilst keeping key anatomical constructions. This way reduces the chance of headaches, comparable to incontinence or erectile disorder.
In spite of everything, the device is designed to streamline the surgical workflow with options like an built-in tower for setup, an adjustable touchscreen for higher ergonomics, and user-friendly tool to steer surgeons via every step of the process.
Those developments supply a extra exact and patient-friendly remedy possibility in comparison to conventional strategies, addressing not unusual demanding situations comparable to tissue injury and undesirable unwanted effects.
To extend get right of entry to to this cutting edge era, The Mount Sinai Health facility has prioritized coaching for its urology workforce. Dr. Kaplan, who has carried out smartly over 400 aquablation procedures with the sooner type, not too long ago finished complex HYDROS coaching. He’ll be joined through Mount Sinai surgeons who will start acting the process within the coming months.
“This new technology is part of our commitment to delivering the most advanced and patient-centered care,” says Dr. Kaplan. “The positive outcomes we’ve seen so far are a testament to the potential of HYDROS to redefine how we approach BPH treatment.”
With this milestone, Mount Sinai continues to determine itself as a pacesetter in robot surgical care. The workforce plans to trace affected person results carefully to give a contribution to a rising frame of proof supporting the advantages of HYDROS treatment for males with BPH.
The HYDROS™ Robot Device, advanced through PROCEPT BioRobotics® Company, gained FDA 510(ok) clearance on August 21, 2024.
Supply:
Mount Sinai Well being Device
Author : admin
Publish date : 2025-01-27 16:40:15
Copyright for syndicated content belongs to the linked Source.